Abstract:Elevated C-reactive protein (CRP) level has been demonstrated in patients with coronary artery disease after coronary stent implantation, but no data are available in patients with atherosclerotic renal artery stenosis concerning whether such changes of CRP also exist after renal artery stent implantation. The authors hypothesize that elevated CRP level may also be present in patients with atherosclerotic renal artery stenosis after stent implantation owing to mechanical disruption of atherosclerotic plaque. In total, 24 patients were enrolled in this study. Of these, 14 patients with atherosclerotic renal artery stenosis received renal angioplasty plus stent implantation (group A, mean age 51 +/- 8 years), and 14 age- and gender-matched patients underwent renal angiography for diagnostic purpose as a control group (group B, mean age 50 +/- 8 years). Peripheral blood samples were taken before the procedure and at 6 and 24 hours after the procedure in both groups. Plasma CRP concentration was measured by using immunoturbidimetry. The results showed that there was no difference in clinical characteristics or in baseline CRP levels between the 2 groups. However, median CRP level was found to increase significantly at 6 hours from 0.13 to 0.17 mg/dL (p < 0.05), and peaked at 24 hours (0.21 mg/dL) after renal artery stent implantation (p < 0.001). Mean CRP rose from 0.30 +/- 0.09 to 0.37 +/- 0.15 mg/dL at 6 hours (p < 0.05) and peaked at 24 hours (0.43 +/- 0.18 mg/dL) after renal artery stent implantation (p < 0.01), while no such changes were observed after renal angiography in group B (p > 0.05, respectively, at different time points). The results of the present study indicate, from evidence of increased plasma CRP concentrations, that renal artery stent implantation could trigger an inflammatory response due to mechanical disruption of atherosclerotic plaque of the renal artery, which is a pattern very similar to that of coronary stent implantation.

Effect of Rapamycin Eluting Stent on Level of C-reactive Protein in Patients with Acute Coronary Syndrome After Angioplasty

Effects of Different Doses of Rosuvastatin on High-sensitivity C-reactive Protein(hs-CRP) and Interleukin-6 (IL-6) in Patients with Acute Coronary Syndrome.

The Serum Levels of High Sensitivity C-reactive Protein and Cardiac Events after Percutaneous Coronary Intervention

The Study of the Relation Between C-reactive Protein,fibrinogen and Acute Coronary Syndrome

Predictive Value of Baseline C-reactive Protein for Periprocedural Myocardial Infraction of Higher Risk Stratifications: A Retrospective Cohort Clinical Study

The Clinical Effect of Homemade Rapamycin-Eluting Stent on Acute Myocardial Infarction

The Value of Preprocedural Serum Levels of C-reactive Protein in Predicting Cardiovascular Events and Restenosis after Coronary Stent Implantation

Effect comparison of domestic rapamycin eluting stent versus imported rapamycin eluting stent in patients with coronary atherosclerotic heart disease

Relationship of Preprocedural High Sensitivity C-reactive Protein and Restenosis after Coronary Angioplasty of Unprotected Left Main Coronary Artery Stenosis

Change of CRP content in plasma of carotid stenosis patients with angioplasty and the effect of simvastatin on its change

The Clinical Contrast Investigation of Rapamycin Eluting Stent Between Domestic-Made and Imported

Increased C-reactive protein level after renal stent implantation in patients with atherosclerotic renal stenosis.

Clinical Study of the Use of Rapamycin Eluting Etent

Effect of valsartan on level of C-reactive protein in acute coronary syndrome patients after PCI

The Long-Term Prognostic Significance of High-Sensitive C-reactive Protein to In-Stent Restenosis.

Effects of Clopidogrel on Hs-Crp and TNF-α in Non-St-segment Elevation Acute Coronary Artery Syndromes Patients

Rapamycin to Prevent Artery Restenosis after Stent Implantation:An Intravascular Ultrasound Study

Clinic Application of Dometic Produced Rapamycin Eluting Steut Implanting in Patient with Acote Myocardial Ifarction Receiving Ewergeucy Pdvcataueous Corouary Intervention

Comparison of Effects of Diffetent Drug-Dluting Stents on Serum C-rection Protein and Interleukin-6 Levels

Impact of intensified statin therapy prior to percutaneous coronary intervention on high-sensitivity Creactive protein and von willebrand factor in patients with non-ST segment elevation acute coronary syndrome

Predictive Value of Pre-procedural High Sensitivity C-Reactive Protein in Patients with Unprotected Left Main Coronary Artery after Drug Eluting Stents Implantation